CHEMICAL/BIOLOGICAL DEFENSE (APPLIED RESEARCH)

Abstract

This program element (PE) resources Applied Research across the Mitigate, Protect, and Understand portfolios. Chemical and Biological Defense Program (CBDP) investments provide an integrated, layered capability to enable combating weapons of mass destruction (CWMD) missions ranging from combat operations to Department of Defense (DoD) support to domestic incident prevention and response. The Projects in this PE support applied research in the areas of physical technologies, non-traditional agent (NTA) medical and physical defense technologies, and medical technologies. These investments are a key component to sustaining the core physical and intellectual chemical and biological (CB) defense infrastructure of the Department and support delivery of capabilities, assessments of emerging threats, and the ability to surge unique capabilities in response to a CB event. FY23 funding accelerates characterization and situational awareness of emerging biothreats and accelerates delivery of improved protection from and mitigation of biothreats, including rapid repurposing of available therapeutics and development of new vaccines. Individual projects include: - Mitigate (MT2): Improvement of CB defense material, including contamination avoidance, and decontamination. Development of drug treatments, therapeutics, patient decontamination technologies and individual protection advancements. - Protect (PT2): Development of antidotes, disease surveillance medical technologies, vaccines, and, nerve agent pretreatments. Improvement of protection technologies and biological weapon/agent surveillance. - Understand (UN2): Development of next generation chemical and biological hazard detectors, point-of-need diagnostic devices, and next generation diagnostics systems. - Chemical Biological Defense (CB2) and Techbase Medical Defense (TM2) are no longer active FY23 Projects due to budget restructure. CBDP Science and Technology (S&T) Applied Research Stakeholders: U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), United States Army Medical Research Institute of Infectious Diseases (USAMRIID), United States Army Medical Research Institute of Chemical Defense (USAMRICD), United States Army Natick Soldier Systems Center, Naval Research Lab (NRL), Air Force Research Lab (AFRL), among others. The intent is to maintain strategic partnerships with the DoD Service communities for mission success across the enterprise through collaborative planning and programming maintaining budget assurance. The FY 2022 funding request was reduced by $-1.931 million to account for the availability of prior year execution balances. Efforts under this PE will transition to or will provide risk reduction for Advanced Technology Development (PE 0603384BP), Advanced Component Development and Prototypes (PE 0603884BP), and System Development and Demonstration (PE 0604384BP) activities.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2023
Source ID
0602384BP_2_0400_PB_2023
Change Summary Explanation
Funding: FY 2021 (-$8.065 Million): Below threshold reprogramming to increase advanced development programs for implementation of common CBRN integrated systems architecture within the CBRN Integrated Early Warning (CBRN IEW) program, Joint Biological Tactical Detection System (JBTDS) program test and evaluation, and Man Portable Diagnostic System (MPDS) product development. FY 2021 (-$4.700 Million): Transfer of funding to support Small Business Innovative Research/Small Business Technology Transfer efforts. FY 2022 (+$3.000 Million): Congressional Add for tularemia medical countermeasure. FY 2023: Funding increase reflects the fact that the FY 2022 President's Budget request did not include out-year funding. Funding includes specific increases for enhanced biodefense and pandemic preparedness investments (+$35.500 Million), prophylaxis treatments for biological and emerging threats (+$6.192 Million), collective protection efforts (+$3.544 Million), and Departmental inflation rate adjustments (+$1.456 Million). Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Artificial Intelligence
  • Biological Factors
  • Biological Toxins
  • Brain Injuries
  • Chemical Warfare
  • Chemical Warfare Agents
  • Chemistry
  • Detection
  • Equine Encephalitis
  • Health Services
  • Materials Testing
  • Medical Personnel
  • Synthetic Biology
  • Test And Evaluation
  • Test Methods
  • Vaccines
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.
  • Military Science and Technology Research and Modernization.

Technology Areas

  • Biotechnology

Related Documents